Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler Janovitz

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|July 5, 2023
Genomic landscape of clinically advanced <i>KRAS</i> wild-type pancreatic ductal adenocarcinomaPrashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, et al.
Nature Biotechnology|January 19, 2010
Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependentDaylon James, Hyung-song Nam, Marco Seandel, et al.
Gynecologic Oncology|January 9, 2022
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroupsDouglas I Lin, Alexander Fine, Natalie A Danziger, et al.
Scientific Reports|March 17, 2023
Predicting EGFR mutational status from pathology images using a real-world datasetJames J Pao, Mikayla Biggs, Daniel Duncan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
LINE-1 retrotransposition is a recurrent cause of <i>MET</i> exon 14 skipping in cancerJennifer A Karlow, Callan O'Connor, Radwa Sharaf, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
The Oncologist|May 13, 2022
Variable Genomic Landscapes of Advanced Melanomas with Heavy PigmentationRichard S P Huang, Julie Y Tse, Lukas Harries, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|July 5, 2023
Genomic landscape of clinically advanced <i>KRAS</i> wild-type pancreatic ductal adenocarcinomaPrashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, et al.
Nature Biotechnology|January 19, 2010
Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is Id1 dependentDaylon James, Hyung-song Nam, Marco Seandel, et al.
Gynecologic Oncology|January 9, 2022
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroupsDouglas I Lin, Alexander Fine, Natalie A Danziger, et al.
Scientific Reports|March 17, 2023
Predicting EGFR mutational status from pathology images using a real-world datasetJames J Pao, Mikayla Biggs, Daniel Duncan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
LINE-1 retrotransposition is a recurrent cause of <i>MET</i> exon 14 skipping in cancerJennifer A Karlow, Callan O'Connor, Radwa Sharaf, et al.
Frontiers in Oncology|March 6, 2024
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkersDouglas I Lin, Richard S P Huang, Ioannis Ladas, et al.
The Oncologist|May 13, 2022
Variable Genomic Landscapes of Advanced Melanomas with Heavy PigmentationRichard S P Huang, Julie Y Tse, Lukas Harries, et al.
Thyroid : Official Journal of the American Thyroid Association|July 14, 2024
<i>FGFR</i> Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid MalignancyMark F Sabbagh, Tyler Janovitz, Dora Dias-Santagata, et al.
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
Pageof 3